Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Lijuan Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-4988-9720; OpenAlex author ID A5100617936. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 9

  1. CUL2 confers ferroptosis resistance in pancreatic cancer by disrupting KEAP1-mediated NRF2 degradation. Co-author DOI 10.1186/s12935-025-04005-4↗
  2. Retraction Note: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-023-02595-3↗
  3. Erratum: Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Co-author PMID 38074805↗
  4. Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1/RIP3 and synergizes the activity of gemcitabine. Co-author PMID 29312502↗
  5. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Co-author DOI 10.1016/j.canlet.2015.12.002↗
  6. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-016-0301-7↗
  7. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer. Last author DOI 10.1016/j.biopha.2015.05.020↗
  8. Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. Co-author DOI 10.1371/journal.pone.0018434↗
  9. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. Co-author DOI 10.1371/journal.pone.0027684↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Congying Chen · 6 shared papers, 2015–2023 · strength 0.59
  2. Guoyong Hu · 7 shared papers, 2011–2023 · strength 0.59
  3. Rong Wan · 5 shared papers, 2015–2023 · strength 0.42
  4. Li Huang · 2 shared papers, 2023 · strength 0.36
  5. Xingpeng Wang · 5 shared papers, 2011–2023 · strength 0.32
  6. Dachuan Qi · 1 shared paper, 2025 · strength 0.25
  7. Kui Yu · 1 shared paper, 2025 · strength 0.25
  8. Yue Zeng · 1 shared paper, 2023 · strength 0.17
  9. Weiliang Jiang · 3 shared papers, 2015–2016 · strength 0.15
  10. Li Huang · 2 shared papers, 2016–2017 · strength 0.13
  11. Bin Hu · 1 shared paper, 2016 · strength 0.05
  12. Yingying Lu · 1 shared paper, 2015 · strength 0.05
  13. Xiaohua Jiang · 1 shared paper, 2016 · strength 0.05
  14. Xuanfu Xu · 2 shared papers, 2011 · strength 0.05
  15. Shanshan He · 2 shared papers, 2011 · strength 0.05
  16. Feng Wang · 2 shared papers, 2011 · strength 0.05
  17. Chuanyong Guo · 2 shared papers, 2011 · strength 0.05
  18. Yinshi Huang · 1 shared paper, 2011 · strength 0.02
  19. Wenhui Mo · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.